ASCO 2022: Direct Oral Anticoagulants Outperform Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Glioblastoma
Findings raise questions as to whether glioblastoma patients could benefit from prophylaxis with direct oral anticoagulants
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.